PirateBay Download | schmidt h reactive oxygen species network pharmacology therapeutic apps 2021

schmidt h reactive oxygen species network pharmacology therapeutic apps 2021

Type:: E-books
Files:: 2
Size:: 10.8 MB
Uploaded On:: July 15, 2024, 2:36 p.m.
Added By:: andryold1
Seeders:: 3
Leechers:: 13
Info Hash:: 8387053B47042A1C7524370F4C5D599BDB090BD0

Textbook in PDF format Reactive oxygen species (ROS) have been implicated in almost every human disease phenotype, without much, if any, therapeutic consequence foremost exemplified by the failure of the so-called anti-oxidants. This book is a game changer for the field and many clinical areas such as cardiology and neurology. The term ‘oxidative stress’ is abandoned and replaced with a systems medicine and network pharmacology-based mechanistic approach to disease. The ROS-related drugs discussed here target either ROS- forming or ROS -modifying enzymes for which there is strong clinical evidence. In addition, ROS targets are included as they jointly participate in causal mechanisms of disease. This approach is transforming the ROS field and represents a breakthrough in redox medicine indicating a path to patient benefit. In the coming years more targets and drugs may be discovered, but the approach will remain the same and this book will thus become, and for many years remain, the leadingreference for ROSopathies and their treatment by network pharmacology. Chapter "Soluble Guanylate Cyclase Stimulators and Activators" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com. Preface ROS Revisited: Changing the Focus from Oxidative Stress and Redox Biology to Redox Medicine Demystifying Oxidative Stress Oxidants in Physiological Processes Network Medicine-Based Unbiased Disease Modules for Drug and Diagnostic Target Identification in ROSopathies Targeting Antioxidant Responses Development of Telintra as an Inhibitor of Glutathione S-Transferase P Perspectives on the Clinical Development of NRF2-Targeting Drugs Inhibiting ROS Formation and Toxification NOX Inhibitors: From Bench to Naxibs to Bedside Nitric Oxide Synthase Inhibitors into the Clinic at Last Xanthine Oxidoreductase Inhibitors Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches Inhibition of Myeloperoxidase Stimulating/Substituting ROS Effects of Mammalian Thioredoxin Reductase Inhibitors Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO) and Nitroxyl (HNO), in the Setting of Reactive O... Tetrahydrobiopterin and Nitric Oxide Synthase Recouplers Repairing ROS Damage Soluble Guanylate Cyclase Stimulators and Activators Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation

Get This Torrent

Readme_Finish.txt 959 bytes
Schmidt H. Reactive Oxygen Species. Network Pharmacology...Therapeutic Apps 2021.pdf 10.8 MB

Details for: Schmidt H. Reactive Oxygen Species. Network Pharmacology...Therapeutic Apps 2021

schmidt h reactive oxygen species network pharmacology therapeutic apps 2021

Similar Posts: